Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations
- PMID: 12803577
- DOI: 10.1046/j.1472-8206.2003.00148.x
Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations
Erratum in
- Fundam Clin Pharmacol. 2004 Jun;18(3):397
Abstract
Cytochrome P450 2C9 (CYP2C9) is a polymorphic enzyme responsible for the metabolism of different drugs with low therapeutic index such as oral anticoagulants. CYP2C9*2 and CYP2C9*3 are two single nucleotide polymorphic allelic variants. The frequency of these alleles in different ethnic populations is extremely variable. In this study, we compared the frequencies of CYP2C9 allelic variants among 394 Chinese living in Shanghai to 151 French Caucasians living in Paris. The allelic frequencies of CYP2C9 variants of the Chinese and the French subjects were 0.963, 0.001, 0.036 and 0.77, 0.15, 0.08 for CYP2C9*1, CYP2C9*2, CYP2C9*3, respectively. Chinese CYP2C9*3 allelic frequency was twice as lower as the French subjects, but three times higher than Korean (0.036 vs. 0.011). The CYP2C9*2 allele could be detected in only one Chinese subject, whereas it represented the major allelic variant in French Caucasians. The low frequency of the CYP2C9*2 and CYP2C9*3 allelic variants in Chinese subjects does not justify their detection in clinical practice, unlike French Caucasians.
Similar articles
-
CYP2C9 allelic variants: ethnic distribution and functional significance.Adv Drug Deliv Rev. 2002 Nov 18;54(10):1257-70. doi: 10.1016/s0169-409x(02)00076-5. Adv Drug Deliv Rev. 2002. PMID: 12406644 Review.
-
Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.Br J Clin Pharmacol. 2002 Jun;53(6):596-603. doi: 10.1046/j.1365-2125.2002.01604.x. Br J Clin Pharmacol. 2002. PMID: 12047484 Free PMC article.
-
Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.Genet Mol Res. 2010 Sep 14;9(3):1844-51. doi: 10.4238/vol9-3gmr938. Genet Mol Res. 2010. PMID: 20845310
-
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.Pharmacogenetics. 1996 Aug;6(4):341-9. doi: 10.1097/00008571-199608000-00007. Pharmacogenetics. 1996. PMID: 8873220
-
The pharmacogenetics of the response to warfarin in Chinese.Br J Clin Pharmacol. 2012 Mar;73(3):340-7. doi: 10.1111/j.1365-2125.2011.04097.x. Br J Clin Pharmacol. 2012. PMID: 22023024 Free PMC article. Review.
Cited by
-
Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit.Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S13-S19. doi: 10.1016/j.ihj.2018.02.005. Epub 2018 Mar 1. Indian Heart J. 2018. PMID: 30595245 Free PMC article.
-
Frequencies of CYP2C9 polymorphisms in a Syrian cohort.BMC Genomics. 2025 Feb 13;26(1):140. doi: 10.1186/s12864-025-11310-9. BMC Genomics. 2025. PMID: 39948503 Free PMC article.
-
Cytochrome P450 2C9-CYP2C9.Pharmacogenet Genomics. 2010 Apr;20(4):277-81. doi: 10.1097/FPC.0b013e3283349e84. Pharmacogenet Genomics. 2010. PMID: 20150829 Free PMC article. Review. No abstract available.
-
Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.Int J Clin Exp Med. 2015 Nov 15;8(11):21024-33. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885033 Free PMC article.
-
Lipid-lowering effect of fluvastatin in relation to cytochrome P450 2C9 variant alleles frequently distributed in the Czech population.Med Sci Monit. 2012 Aug;18(8):CR512-517. doi: 10.12659/msm.883272. Med Sci Monit. 2012. PMID: 22847201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources